KFDA approved once-a-week dose of Enbrel

Published: 2005-07-26 07:00:00

Updated: 2005-07-26 07:00:00

The KFDA approved once a week administering dose of Enbrel of Wyeth Korea Inc., a drug for the treatment of rheumatoid arthritis, 25mg of which previously approved for twice a week dose of 3 to 4 days interval.

Wyeth Korea said that the efficacy and tolerance of Enbrel once-a-week administrat...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK